Robert McNamara Buys 10,000 Shares of AVITA Medical, Inc. (ASX:AVH) Stock

AVITA Medical, Inc. (ASX:AVH) insider Robert McNamara acquired 10,000 shares of the stock in a transaction on Friday, February 21st. The stock was bought at an average cost of A$10.09 ($6.27) per share, with a total value of A$100,900.00 ($62,670.81).

AVITA Medical Price Performance

The stock has a market cap of $226.55 million, a PE ratio of -5.55 and a beta of 1.54. The company has a debt-to-equity ratio of 0.36, a quick ratio of 9.32 and a current ratio of 8.18.

AVITA Medical Company Profile

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.